LAST CHANCE TO SAVE! New Trends for Food at PACK EXPO Southeast
Discover all the latest packaging & processing solutions for food products at the all-new PACK EXPO Southeast in Atlanta, GA, March 10-12, 2025
Register ASAP for just $30!

New Drug Uses DNA Rather Than Tumor Type to Treat Cancer

The FDA just approved Loxo Oncology’s Vitrakvi drug that treats cancer in an unconventional way.

Cancer Cells in a Tray / Image: Suzanne Plunkett
Cancer Cells in a Tray / Image: Suzanne Plunkett

Most cancer treatments on the market are developed for specific types of cancer and seek approval for that one kind before organizing trials for other cancers. However, a recent Business Insider article discussed a new cancer treatment that focuses on the genetics of the patient. Loxo Oncology developed the drug, Vitrakvi, in partnership with Bayer.

Vitrakvi works for patients whose cancer tests positive for a type of mutation called a gene fusion in a gene called the neurotropic receptor tyrosine kinase, NTRK. For adults, the drug comes in 30-day supplies of 100-milligram capsules, and the cost is $393,600 annually. The liquid oral formulation for children and some adults will cost $121,000 annually. However, Bayer insists the out-of-pocket expense for the majority of patients will be $20 or less.

LAST CHANCE TO SAVE! New Trends for Food at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to food packaging and processing challenges. Don’t miss this extraordinary opportunity for your business!
REGISTER ASAP FOR $30!
LAST CHANCE TO SAVE! New Trends for Food at PACK EXPO Southeast